Albert David Ltd - ALBERT DAVID Share Price

Sector: Pharmaceuticals | ISIN: INE155C01010
₹ 1,343.50 (-0.68%) icon26 Feb, 2024, 12:00:00 AM

Albert David Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 2/26/2024 12:00:00 AM

    ₹ 1343.5 -9.15 -0.68
  • Open
  • ₹ 1,352.65
  • Prev. Close
  • ₹ 1,352.65
  • Turnover(Lac.)
  • ₹ 0
  • Day's High
  • ₹ 1,370
  • Day's Low
  • ₹ 1,336.25
  • 52 Week's High
  • ₹ 1,607.9
  • 52 Week's Low
  • ₹ 505.95
  • Book Value
  • ₹ 655.14
  • Face Value
  • ₹ 10
  • Mkt Cap (₹ Cr.)
  • 767.14
  • P/E
  • 11.6
  • EPS
  • 116.01
  • Divi. Yield
  • 0.67

Albert David Ltd Corporate Actions

25 Jan , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

25 Jan , 2024

12:00 AM

01 Nov , 2023

12:00 AM

01 Nov , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

01 Nov , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

02 Aug , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

19 May , 2023

12:00 AM

AGM

Announcement date: 19 May , 2023

View Details

02 Aug , 2023

12:00 AM

19 May , 2023

12:00 AM

Dividend

Dividend amount: 9
Announcement date: 19 May , 2023

View Details

11 May , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

14 Jul , 2023

12:00 AM

BookCloser

View Details

Albert David Ltd News and Update

Image not found
  • 23 February, 2024 |
  • 12:07 AM

Under the "ILS Hospitals" brand, GPT Healthcare Ltd. manages a network of mid-sized full-service hospitals that offer integrated healthcare services, with an emphasis on secondary and tertiary care.

Image not found
  • IIFL News Service |
  • 22 February, 2024 |
  • 12:06 AM
Image not found
  • IIFL News Service |
  • 22 February, 2024 |
  • 12:06 AM
Image not found
  • IIFL News Service |
  • 16 February, 2024 |
  • 11:57 PM

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Albert David Ltd SHAREHOLDING SNAPSHOT
27 February , 2024 | 08:22 AM

PROMOTER - TOTAL62.04%

Indian: 62.04%

Foreign: 0%

NON-PROMOTER - TOTAL 37.96%

Institutions: 2.36%

Non-Institutions: 35.59%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

Albert David Ltd FINANCIALS

No Data Available To Display Chart

Albert David Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Albert David Ltd

  • A K Kothari
  • Executive Chairman
  • Hemal Kampani
  • Independent Director
  • Rajiv Singhi
  • Independent Director
  • Prabhawati Devi Kothari
  • Director
  • Arindam Sarkar
  • Independent Director
  • Shirish Gundopant Belapure
  • Independent Director
  • Monjori Mitra
  • Independent Director
  • Anand Vardhan Kothari
  • Director
  • A B Chakrabarty
  • Company Sec. & Compli. Officer
  • U. M. Kunte
  • Managing Director & CEO

Summary

Albert David Limited (ADL), a Unit of Kothari Group, was incorporated in 1938 at Calcutta. The Company belongs to a renowned industrial house of Kolkata, the Kothari Group. The Companys principal business is manufacturing and trading of Pharmaceutical Formulations, Infusion Solutions, Herbal Dosage Forms and Bulk Drugs by way of domestic sale or export. Apart from these, it manufactures disposable syringes and needles and a wide range of bulk drugs. It is recognised as a large IV fluid manufacturer, both in glass and polyethylene containers.ADL has entered into a technical collaboration with Morishita Pharmaceuticals, Japan, a subsidiary of Ajinomoto -- the world leader in amino acids -- to manufacture amino acid infusions, for which it came out with a rights issue in Aug.87. It has also set up a new unit in Kalyani, West Bengal, to manufacture bulk drugs, which went on stream in 1990. Another rights issue in Mar.90 augmented the long-term working capital. ADL has entered into technical collaboration with Pharma Plan, Germany, to supply machinery to manufacture 30 mln disposable syringes and 70 mln needles at Mandideep near Bhopal. ADL came up with a Rs 4.68-cr right issue to part finance the expansion of its capacity of IV fluids in plastic bottles (FFS technology) at Ghaziabad.During 1998-99, the company has developed some new products viz. Siozole Capsules and Ferrochelate-Z-Capsules with Iron & Zinc and folic acid in sustained released formulation. In 2002-03 the company... Read More


Reports by Albert David Ltd


Reports by Albert David Ltd

Company FAQ

No Record Found